Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer (NSCLC): Initial analysis of a randomized phase III trial
Author:
Affiliation:
1. University of Chicago, Chicago, IL; Duke University Medical Center, Durhan, NC; Duke University & Durham VA Hospital, Durham, ND; University of Massachusetts Health Center, Worcester, MA; Medical University of South Carolina, Charleston, SC
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.90140.7005
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recent Advances in Combined Modality Therapy;The Oncologist;2010-03-09
2. Non-small Cell Lung Cancer;Handbook of Evidence-Based Radiation Oncology;2010
3. Biological Agents in Non-small Cell Lung Cancer: A Review of Recent Advances and Clinical Results with a Focus on Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor;Journal of Thoracic Oncology;2008-06
4. Induction Chemotherapy Before Chemoradiation in Locally Advanced Non–Small-Cell Lung Cancer: Failure After Failure, Again and Again;Journal of Clinical Oncology;2008-04-01
5. Phase I/II trial of biweekly docetaxel and cisplatin with concurrent thoracic radiation for stage III non-small-cell lung cancer;Cancer Chemotherapy and Pharmacology;2006-03-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3